Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.
Biochem Biophys Res Commun
; 545: 33-39, 2021 03 19.
Article
em En
| MEDLINE
| ID: mdl-33535104
ABSTRACT
Zika virus (ZIKV) infection in both infants and adults is associated with neurological complications including, but not limited to, microcephaly and Guillain-Barre syndrome. Antibody therapy can be effective against virus infection. We isolated ZIKV envelope domain III-specific neutralizing antibodies (nAbs) from two convalescent patients with ZIKV infection. One antibody, 2F-8, exhibited potent in vitro neutralizing activity against Asian and American strains of ZIKV. To prevent FcγR-mediated antibody-dependent enhancement, we prepared IgG1 with LALA variation. A single dose of 2F-8 in the context of IgG1 or IgG1-LALA prior to or post lethal ZIKV challenge conferred complete protection in mice.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Proteínas do Envelope Viral
/
Anticorpos Neutralizantes
/
Zika virus
/
Anticorpos Monoclonais
/
Anticorpos Antivirais
Limite:
Animals
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Biochem Biophys Res Commun
Ano de publicação:
2021
Tipo de documento:
Article